Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study

[1] Aron AR(2004)Inhibition and the right inferior frontal cortex Trends Cogn Sci 8 170-177

[2] Robbins TW(2003)N-acetyl cysteine-induced blockade of cocaine-induced reinstatement Ann NY Acad Sci 1003 349-351

[3] Poldrack RA(2004)Acute effects of memantine in combination with alcohol in moderate drinkers Psychopharmacol 172 16-24

[4] Baker DA(2004)An open-label trial of bupropion in the treatment of pathologic gambling J Clin Psychopharmacol 24 108-110

[5] McFarland K(2008)Extended release carbamazepine in the treatment of pathological gambling: an open-label study Prog Neuropsychopharmacol Biol Psychiatry 32 1191-1194

[6] Lake RW(2002)A pilot placebo-controlled study of fluvoxamine for pathological gambling Ann Clin Psychiatry 14 9-15

[7] Shen H(1998)Taking chances: problem gamblers and mental health disorders—results from the St. Louis Epidemiologic Catchment Area study Am J Publ Health 88 1093-1096

[8] Toda S(2007)A pilot double-blind treatment trial of memantine for alcohol dependence Alcohol Clin Exp Res 31 775-782

[9] Kalivas PW(2008)Memantine for the treatment of Alzheimer’s disease: tolerability and safety data from clinical trials Drug Saf 31 577-585

[10] Bisaga A(1993)Clinical validation of the quality of life inventory: a measure of life satisfaction for use in treatment planning and outcome assessment Psychol Assess 4 92-101

[1] Aron AR(2004)Inhibition and the right inferior frontal cortex Trends Cogn Sci 8 170-177

[2] Robbins TW(2003)N-acetyl cysteine-induced blockade of cocaine-induced reinstatement Ann NY Acad Sci 1003 349-351

[3] Poldrack RA(2004)Acute effects of memantine in combination with alcohol in moderate drinkers Psychopharmacol 172 16-24

[4] Baker DA(2004)An open-label trial of bupropion in the treatment of pathologic gambling J Clin Psychopharmacol 24 108-110

[5] McFarland K(2008)Extended release carbamazepine in the treatment of pathological gambling: an open-label study Prog Neuropsychopharmacol Biol Psychiatry 32 1191-1194

[6] Lake RW(2002)A pilot placebo-controlled study of fluvoxamine for pathological gambling Ann Clin Psychiatry 14 9-15

[7] Shen H(1998)Taking chances: problem gamblers and mental health disorders—results from the St. Louis Epidemiologic Catchment Area study Am J Publ Health 88 1093-1096

[8] Toda S(2007)A pilot double-blind treatment trial of memantine for alcohol dependence Alcohol Clin Exp Res 31 775-782

[9] Kalivas PW(2008)Memantine for the treatment of Alzheimer’s disease: tolerability and safety data from clinical trials Drug Saf 31 577-585

[10] Bisaga A(1993)Clinical validation of the quality of life inventory: a measure of life satisfaction for use in treatment planning and outcome assessment Psychol Assess 4 92-101